Calumet enterprises manufactures sniffstop cold medicine


Calumet Enterprises manufactures Sniffstop cold medicine using a process costing system. The processing department has a single direct-cost category (direct materials) and a single indirect-cost category (conversion costs). Direct materials are added at the beginning of the process. In May there were 6,000 gallons of the product in the beginning inventories that were 60% complete as to conversion. Calumet started 18,200 gallons into production and had 7,000 gallons in ending inventory in May (the ending inventory was 40% complete as to conversion). The following cost data were available for May:

Beginning inventory:

Direct materials, $45,696

Conversion costs, $30,912

Costs added this period:

Direct materials, $81,354

Conversion costs, $97,088

REQUIRED: (round to nearest penny)

1. Prepare a cost of production report using the weighted average method to assign costs to ending work-in-process and costs transferred out.

2. Prepare a cost of production report using the weighted FIFO method to assign costs to ending work-in-process and costs transferred out.

Request for Solution File

Ask an Expert for Answer!!
Financial Accounting: Calumet enterprises manufactures sniffstop cold medicine
Reference No:- TGS01690564

Expected delivery within 24 Hours